OKT3 therapy for accelerated acute rejection.
Van Buren
D H
DH
Vanderbilt University Medical Center, Department of Renal Transplantation, Nashville, Tennessee.
Richie
R E
RE
Nylander
W A
WA
D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D005260:Female; D006084:Graft Rejection; D006801:Humans; D007165:Immunosuppression Therapy; D016030:Kidney Transplantation / Q000009:adverse effects* / Q000276:immunology; D016176:T-Lymphocyte Subsets / Q000276:immunology
D000911:Antibodies, Monoclonal